National Institutes of Health Funding for Tuberculosis Comorbidities Is Disproportionate to Their Epidemiologic Impact.
Madeline E CarwileSusie Jiaxing PanVictoria ZhangMadolyn DauphinaisChelsie CintronDavid FlynnAlice M TangPranay SinhaPublished in: Open forum infectious diseases (2023)
Tuberculosis (TB) is a leading infectious killer worldwide. We systematically searched the National Institutes of Health Research, Portfolio Online Reporting Tools Expenditures and Results (RePORTER) website to compare research funding for key TB comorbidities-undernutrition, alcohol use, human immunodeficiency virus, tobacco use, and diabetes-and found a large mismatch between the population attributable fraction of these risk factors and the funding allocated to them.
Keyphrases
- human immunodeficiency virus
- mycobacterium tuberculosis
- risk factors
- hiv aids
- hepatitis c virus
- antiretroviral therapy
- quality improvement
- pulmonary tuberculosis
- adverse drug
- health information
- type diabetes
- hiv infected
- healthcare
- cardiovascular disease
- public health
- crispr cas
- social media
- mental health
- hiv positive
- health insurance
- glycemic control
- emergency department
- risk assessment